Warfarin News and Research

RSS
Warfarin is a drug that prevents blood from clotting. It belongs to the family of drugs called anticoagulants (blood thinners).
Daiichi Sankyo initiates Phase III trial of edoxaban in reducing recurrent VTE complications

Daiichi Sankyo initiates Phase III trial of edoxaban in reducing recurrent VTE complications

Medco Health Solutions acquires DNA Direct

Medco Health Solutions acquires DNA Direct

Romark Laboratories commences enrollment in Alinia clinical trial for acute uncomplicated influenza

Romark Laboratories commences enrollment in Alinia clinical trial for acute uncomplicated influenza

QIAGEN hosts panel discussion to educate public about the emerging promise of personalized medicine

QIAGEN hosts panel discussion to educate public about the emerging promise of personalized medicine

Treatment with Effient more cost effective, show TRITON-TIMI 38 clinical trial results

Treatment with Effient more cost effective, show TRITON-TIMI 38 clinical trial results

ARYx Therapeutics receives guidance in writing from FDA on tecarfarin

ARYx Therapeutics receives guidance in writing from FDA on tecarfarin

Eli Lilly and Kowa Pharmaceuticals America to co-promote LIVALO in the U.S

Eli Lilly and Kowa Pharmaceuticals America to co-promote LIVALO in the U.S

Incyte announces positive results from ongoing Phase I/II clinical trial for INCB7839

Incyte announces positive results from ongoing Phase I/II clinical trial for INCB7839

Latest findings on how blood clots form can open door to the development of new drugs

Latest findings on how blood clots form can open door to the development of new drugs

Fulvestrant 500 mg reduces risk of disease progression in women with metastatic breast cancer

Fulvestrant 500 mg reduces risk of disease progression in women with metastatic breast cancer

Experts call on Europe's policy makers to take urgent action against preventable strokes

Experts call on Europe's policy makers to take urgent action against preventable strokes

New guidelines on the management of antithrombotic agents for endoscopic procedures published

New guidelines on the management of antithrombotic agents for endoscopic procedures published

Dabigatran etexilate prevents recurrent VTE with less bleeding than warfarin

Dabigatran etexilate prevents recurrent VTE with less bleeding than warfarin

New oral drug is safe and effective to combat clotting disorder

New oral drug is safe and effective to combat clotting disorder

Anticoagulants used to prevent clots in placental blood vessels ineffective, reveals research

Anticoagulants used to prevent clots in placental blood vessels ineffective, reveals research

Dabigatran etexilate offers effective therapy to prevent recurrent VTE

Dabigatran etexilate offers effective therapy to prevent recurrent VTE

ISIS-FXIRx and ISIS-SMNRx included in Isis Pharmaceuticals' development pipeline

ISIS-FXIRx and ISIS-SMNRx included in Isis Pharmaceuticals' development pipeline

Sepracor to present clinical study data of STEDESA at the 2009 AES meeting

Sepracor to present clinical study data of STEDESA at the 2009 AES meeting

New data demonstrating the strength of Novartis' hematology portfolio to be presented

New data demonstrating the strength of Novartis' hematology portfolio to be presented

Boehringer Ingelheim to announce positive results from its RE-COVER study

Boehringer Ingelheim to announce positive results from its RE-COVER study

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.